The costs of dialysis in the USA

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 1, 1997, Pages 10-21

  Garella, S ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b S Joseph Health Center and Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DISEASE SEVERITY; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE FINANCING; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEDICARE; MORBIDITY; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PROFIT; REIMBURSEMENT; SALARY; UNITED STATES;

COSTS AND COST ANALYSIS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; UNITED STATES;

EID: 0031051031     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Wagner L. Americans least satisfied with health system. Modern Healthcare 1990; 16 July: 26-28
2. US Department of Commerce. Economics and Statistics Administration. Bureau of the Census. Statistical Abstract of the United States, 1994
3. Burner ST, Waldo DR. National health expenditure projections, 1995-25. Health Care Financing Rev 1995;16: 221-242
4. Himmelstein DU, Woolhander S. Care denied: US residents who are unable to obtain needed medical services. Am J Publ Health 1995; 85: 341-344
5. American College of Physicians. Access to health care. Ann Int Med 1990; 112: 641-661
6. Woolhandler S, Himmelstein DU. The deteriorating administrative efficiency of the U.S. health care system. N Engl J Med 1991; 324: 1253-1258
7. American Hospital Association. Hospital Statistics. AHA Association Data Base, July 1995
8. Levinsky NG, Rettig RA. The Medicare End-Stage Renal Disease Program. A report from the Institute of Medicine. N Engl J Med 1991; 324: 1143-1148
9. Farley DO. Financing of end-stage renal disease care: past, present, and future. Adv Renal Replace Ther 1994; 1: 24-31
10. Medicare Coverage of Kidney Dialysis and Kidney Transplant Services. A Supplement to your Medicare Handbook. U.S. Department of Health and Human Services, Health Care Financing Administration, 1995
11. A Reference Guide to Dialysis Reimbursement. Amgen Inc., 1995
12. National Listing of Medicare Providers Furnishing Kidney Dialysis and Transplant Services, January 1994. U.S. Department of Health and Human Services. Health Care Financing Administration. Bureau of Data Management and Strategy, 1994
13. United States Renal Data System. 1995 Annual Data Report. U.S. Department of Health and Human Services. National Institutes of Health, National Institute of Diabetes and Kidney Disease, Division of Kidney, Urologic, and Hematologic Diseases, Bethesda, MD, 1995
14. Port FK. The End-Stage Renal Disease Program: trends over the past 18 years. Am J Kidney Dis 1992; 20: 3-7
15. Bloembergen We, Port FK, Mauger EA, Wolfe RA. Causes of death in dialysis patients: racial and gender differences. JASN 1994; 5: 1231-1242
16. Anonymous. Percentage of deaths drops despite steady growth in ESRD population. Nephrol News Issues 1995; 9: 15-16
17. Port FK. Nephrology forum: morbidity and mortality in dialysis patients. Kidney Int 1994; 46: 1728-1737
18. Nelson CB, Port Fk, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s, JASN 1992; 3: 1147-1155
19. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45: 1163-1169
20. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with homodialysis and peritoneal dialysis. JASN 1995; 6: 177-183
21. Health Care Financing. End Stage Renal Disease, 1992. Research Report, Department of Health and Human Services, Health Care Financing Administration, Bureau of Data Management and Strategy, Office of Research and Demonstrations, Baltimore, MD, 1994
22. Reitmeijer CA. The cost of AIDS and HIV infection: the experience of a public hospital in the context of national forecasts. Comprehensive Ther 1993; 1: 174-176
23. Medical-care expenditures attributable to cigarette smoking-United States, 1993. JAMA 1994; 272: 428-429
24. The Chicago Tribune, 16 October 1995
25. Anonymous. Administrators of three different dialysis facilities. Personal communications, 1995
26. National Renal Administrators Position Paper on 1996 Composite Rate Update. National Renal Administrators Association, 11512 Allecingie Parkway, Richmond, VA 23235, 1995
27. Eggers PW. Mortality rates among dialysis patients in Medicare's End-Stage Renal Disease Program. Am J Kidney Dis 1990; 15: 414-421
28. Hull AR. Impact of reimbursement regulations on patient management. Am J Kidney Dis 1992; 20(Suppl 1); 8-11
29. Kurtin P, Nissenson ER. Variation in end-stage renal disease patient outcomes: what we know, what should we know, and how do we find out? JASN 1993; 3: 1738-1747
30. Held PJ, Wolfe RA, Gaylin DS, Port FK, Levin NW, Turenne MN. Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 1994; 23: 692-708
31. Shaldon S. Dialyzer reuse: a practice that should be abandoned. Semin Dial 1993; 6: 11-12
32. Held PJ, Port FK, Garcia J, Gaylin DS, Levin NV, Agodoa L. USRDS: hemodialysis prescription and delivery in the U.S.: results from USRDS case mix study [Abstract], JASN 1991; 2: 328
33. Delmez JA, Windus DW, and The St Louis Nephrology Study Group. Hemodialysis prescription and delivery in a metropolitan community. Kidney Int 1992; 41: 1023-1028
34. Sargent J. Shortfalls in the delivery of dialysis. Am J Kidney Dis 1990; 15: 500-510
35. Held PJ, Carroll CE, Liska DW, Turenne MN, Port FK. Hemodialysis therapy in the United States: what is the dose and does it matter? Am J Kidney Dis 1994; 24: 974-980
36. Held PJ, Blagg CR, Liska DW, Port FK, Hakim R, Levin N. The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int 1992; 42(Suppl 38): S19-S21
37. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23: 661-669
38. Parker T. Hemodialysis adequacy. In: Henrich WL, ed. Principles and Practice of Dialysis. Williams and Wilkins, Baltimore, 1994; 63-75
39. Hakim RM, Depner TA, Parker TF III. Adequacy of hemodialysis. Am J Kidney Dis 1992; 20: 107-113
40. Kopple JD, Hakim RM, Held PJ, Keane WF, King K, Lazarus JM, Parker TF III, Teehan BP. Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. Am J Kidney Dis 1994; 26: 968-973
41. Hornberger JC. The hemodialysis prescription and cost effectivenes. JASN 1993; 4: 1021-1027
42. Griffiths RI, Powe NR, Gaskin DJ, Anderson GF, deLissovoy GV, Whelton PK. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. Health Services Res 1994; 29: 473-487
43. Burns J. Dialysis providers cope with dwindling payments. Modern Healthcare 1992; 11 May: 56-57
44. Lore G. Nephrologists discuss how dialysis adequacy affects patient morbidity and mortality. Contemp Dial Nephrol 1995; 16: 24-26